![Omid Farokhzad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Omid Farokhzad
Amministratore Delegato presso
SEER, INC.
Patrimonio netto: 10 M $ in data 30/09/2026
Profilo
Fondatore di 5 diverse aziende, tra cui: Seer, Inc. (California), Selecta Biosciences, Inc. e DNIB Unwind, Inc. Omid C. Farokhzad è un imprenditore ed è presidente e amministratore delegato di Seer, Inc. (California) (che ha fondato nel 2017). È anche nel consiglio di amministrazione di Placon Therapeutics, Inc. Nella sua carriera passata è stato presidente di Selecta Biosciences, Inc. (ha fondato la società nel 2007), professore associato alla Harvard Medical School, direttore di DNIB Unwind, Inc. e direttore di Tarveda Therapeutics, Inc. Il Dr. Farokhzad ha ricevuto un dottorato e una laurea alla Boston University School of Medicine e un MBA al Massachusetts Institute of Technology.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
SEER, INC. CLASS A 7,95% | 11/05/2026 | 4.403.724 ( 7,95% ) | 10 M $ | 30/09/2026 |
Posizioni attive di Omid Farokhzad
| Società | Posizione | Inizio |
|---|---|---|
| SEER, INC. | Amministratore Delegato | 01/03/2018 |
Placon Therapeutics, Inc.
 Placon Therapeutics, Inc. BiotechnologyHealth Technology Develops novel platinum therapies | Direttore/Membro del Consiglio | - |
Xlink Therapeutics, Inc. | Fondatore | - |
PrognomIQ, Inc.
 PrognomIQ, Inc. Medical SpecialtiesHealth Technology Develops and commercializes multi-omics human tests for cancer and other diseases | Fondatore | 01/01/2020 |
Xira Connect, Inc. | Direttore/Membro del Consiglio | 01/08/2019 |
Precedenti posizioni note di Omid Farokhzad
| Società | Posizione | Fine |
|---|---|---|
Senti Biosciences, Inc.
 Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Direttore/Membro del Consiglio | 25/11/2024 |
| DYNC SPL | Presidente | 01/06/2022 |
| CARTESIAN THERAPEUTICS, INC. | Fondatore | 19/11/2019 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Fondatore | 01/01/2019 |
| ░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Omid Farokhzad
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
73
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Semaphore, Inc.
 Semaphore, Inc. Packaged SoftwareTechnology Services Develops and distributes advanced financial and project management software | Technology Services |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Medicine
 Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Placon Therapeutics, Inc.
Placon Therapeutics, Inc. BiotechnologyHealth Technology Develops novel platinum therapies | Health Technology |
Seer, Inc. (California)
 Seer, Inc. (California) BiotechnologyHealth Technology Provides research and development services for biotechnology | Health Technology |
PrognomIQ, Inc.
PrognomIQ, Inc. Medical SpecialtiesHealth Technology Develops and commercializes multi-omics human tests for cancer and other diseases | Health Technology |
Dynamics Special Purpose Corp.
 Dynamics Special Purpose Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Xlink Therapeutics, Inc. | |
Xira Connect, Inc. | |
Senti Biosciences, Inc.
Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Health Technology |
